With WHO support, Libya launches a comprehensive review of its National Immunization Programme
7 May 2025, Tripoli, Libya – With support from the World Health Organization (WHO), the National Centre for Disease Control has launched a comprehensive desk and field review of Libya’s Expanded Programme on Immunization (EPI). The review, which began on 3 May 2025 and will continue until 15 May 2025, is being conducted in partnership with the Ministry of Health and the United Nations Children's Fund (UNICEF). A team of local and international experts is evaluating the performance of the national immunization programme across 12 municipalities and 48 health facilities.
The EPI review, also known as the National Immunization Programme Review, is a systematic assessment of the strengths and weaknesses of the immunization programme at the national, subnational and service delivery levels. It will provide evidence to inform the development of the National Immunization Strategy for 2025 and help align Libya’s efforts with global and regional targets under the Immunization Agenda 2030. Previous studies, including the 2014 Pan Arab Project for Family Health (PAPFAM) and the 2024 post-campaign National Immunization Days report, indicate that measles vaccination coverage among children under 5 is between 70–85%, revealing a possible gap between administrative reporting and population-level coverage.
Libya country office annual report, 2022
